Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

What working in rare disease has taught me about supporting better FOP clinical practice

Ipsen delivers encouraging sales growth in Q1, confirms full-year guidance

Earth Day 2021: A moment to reflect, celebrate and – most importantly – dream big

Ipsen – Q1 Results – Conference Call – April 22, 2021